<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta name="viewport" content="initial-scale=1"><!--[if (mso)|(mso 16)]>
<style type="text/css">a {text-decoration: none;}</style>
<![endif]--><title>Prognosis</title><table id="wrapper" align="center" border="0" cellpadding="0" cellspacing="0" style="max-width: 550px; padding-top: 10px; width: 100%" width="100%">
<!--[if mso]>
<center>
<tr><td>
<table border="0" cellpadding="0" cellspacing="0" width="550">
<![endif]-->
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="brand-hdr">
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9wcm9nbm9zaXM/5daec32c52ba1e0621725115B295facb1">
<!--[if mso]>
<table width="550"><tr><td><img alt="Bloomberg" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/io0pvKRTT7xk/v0/-1x-1.png" width="550" /></td></tr></table>
<div style="display:none">
<![endif]-->
<img class="logo-image" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/io0pvKRTT7xk/v0/-1x-1.png" border="0" alt="Bloomberg" style="width: 100%; max-width: 550px">
<!--[if mso]>
</div>
<![endif]-->
</a>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt"></td>
</tr>
</table>
<table class="social_component" style="width: 100%" width="100%">
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; padding: 0; padding-top: 9px; padding-bottom: 9px; text-transform: uppercase; font-family: Arial; font-size: 12px; font-weight: normal; font-style: normal; font-stretch: normal; line-height: 1.17; letter-spacing: normal; border-right: 10px solid white; border-top: 1px dotted #000000; border-bottom: 1px dotted #000000"><span style="margin-right: 4px;vertical-align: middle">Follow Us</span> <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuZmFjZWJvb2suY29tL2Jsb29tYmVyZ2J1c2luZXNzLw/5daec32c52ba1e0621725115Be1ee4ba5" style="text-decoration: none; color: #000"><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iSTidtzUTVno/v0/-1x-1.png" width="20" height="20" style="vertical-align: middle"> </a><a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly90d2l0dGVyLmNvbS9idXNpbmVzcw/5daec32c52ba1e0621725115B4f0b3845" style="text-decoration: none; color: #000"><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iD_P6YIGeql4/v0/-1x-1.png" width="20" height="20" style="vertical-align: middle"></a></td>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; padding: 0; padding-top: 9px; padding-bottom: 9px; text-transform: uppercase; font-family: Arial; font-size: 12px; font-weight: normal; font-style: normal; font-stretch: normal; line-height: 1.17; letter-spacing: normal; border-left: 10px solid white; border-top: 1px dotted #000000; border-bottom: 1px dotted #000000">
<a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vam9pbi80d20vcHJvZ25vc2lzLXNpZ251cA/5daec32c52ba1e0621725115B707add83" style="text-decoration: none; color: #000">Get the newsletter</a>
</td>
</tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td class="body-copy bbiz-wysiwyg-content" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 150%; padding: 0 10px">
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">Sprawling global pharmaceutical companies want to evolve into nimble innovators, but getting it right is likely to be harder than it sounds.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">France's Sanofi this week became the latest multinational drug behemoth to say that it would try to <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMDkvc2Fub2ZpLXMtbmV3LWNlby1zZWVzLWZ1dHVyZS1pbi1jYW5jZXItbW92aW5nLWJleW9uZC1kaWFiZXRlcz9jbXBpZD1CQkQxMjEyMTlfUFJPRyZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9bmV3c2xldHRlciZ1dG1fdGVybT0xOTEyMTImdXRtX2NhbXBhaWduPXByb2dub3Npcw/5daec32c52ba1e0621725115B95b43d70" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on Sanofi" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none"><meta content="Q2AMWZT0AFB4" itemprop="suid"><meta content="StoryLink" itemprop="type">slim down</a> and focus on finding new treatments for cancer and rare diseases, backing away from the diabetes and heart therapies that for years have been its main source of growth. Other large drugmakers, such as Pfizer, Novartis and GlaxoSmithkline, are busy with similar makeovers after decades of selling chronic-disease treatments and consumer-health products to millions upon millions of people.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">One reason Sanofi is moving that way is price: Innovative drugs command handsome premiums, at times with less political pushback from patients and payers. Further, the chronic-disease blockbusters of the past are fading. Cancer drugs' share of U.S. pharmaceutical revenue almost quadrupled to 28% over the past two decades, while cardiovascular drugs dropped from dominance to 1%, according to Boston Consulting Group.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">More importantly for patients, advances in science are putting potentially <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMTIvbWlyYWNsZS1jYW5jZXItZHJ1Z3MtYXJlLW1ha2luZy1iaWctcGhhcm1hLWJpbGxpb25zLW90aGVycy1hcmUtZ2V0dGluZy1sZWZ0LWJlaGluZD9jbXBpZD1CQkQxMjEyMTlfUFJPRyZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9bmV3c2xldHRlciZ1dG1fdGVybT0xOTEyMTImdXRtX2NhbXBhaWduPXByb2dub3Npcw/5daec32c52ba1e0621725115B73ca05a8" itemprop="StoryLink" itemscope="itemscope" title="Bloomberg article on cancer therapies" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none"><meta content="Q2DV82DWX2Q0" itemprop="suid"><meta content="StoryLink" itemprop="type">dazzling cures</a> in reach, and that has made pharma <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMTIvYmlnLXBoYXJtYS13aWxsLXRhcmdldC1zbWFsbGVyLWRlYWxzLWluLTIwMjAtanBtb3JnYW4tcHJlZGljdHM_Y21waWQ9QkJEMTIxMjE5X1BST0cmdXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX3Rlcm09MTkxMjEyJnV0bV9jYW1wYWlnbj1wcm9nbm9zaXM/5daec32c52ba1e0621725115B78ce7ac5" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on pharmaceutical deals" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none"><meta content="Q2EIZUT0G1KX" itemprop="suid"><meta content="StoryLink" itemprop="type">willing to stretch</a> its resources like never before. One blockbuster cancer therapy can reshape even the biggest company. For example, Merck has been transformed by Keytruda, its top-selling immunotherapy, which could see annual sales of more than $27 billion in six years, more than any drug ever.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">Still, the road to success is <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9vcGluaW9uL2FydGljbGVzLzIwMTktMTItMDkvc2Fub2ZpLWRpYWJldGVzLWRyb3AtYW5kLWNhbmNlci1wdXNoLWlzLWZhbWlsaWFyLXN0cmF0ZWd5P2NtcGlkPUJCRDEyMTIxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTIxMiZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115Be73b5ed6" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg Opinion article on cancer drugs" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none"><meta content="Q29RJ8DWLU68" itemprop="suid"><meta content="StoryLink" itemprop="type">strewn with peril</a>. For every Keytruda, many other drugs fail in the lab or run into the buzzsaw of competition. For Less-Big Pharma, the race is on.—<a href="mailto:tannett@bloomberg.net" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Send email to Tim Annett" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none"><em>Tim Annett</em></a></p>
<h2 style="color: #000000; font-weight: bold; font-family: Arial Black, Arial, Helvetica, sans-serif; letter-spacing: -1px; border-bottom: 1px dotted #000000; padding-bottom: 5px; margin-top: 30px; margin-bottom: 0; font-size: 20px">Here's what else we're watching:</h2>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>DNA deal.</strong> A former Illumina unit is <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMTEvZG5hLXNpdGUtdGhhdC10aGF3ZWQtY29sZC1jYXNlcy1zb2xkLWFzLWZvcmVuc2ljcy1idXNpbmVzcy1ib29tcz9jbXBpZD1CQkQxMjEyMTlfUFJPRyZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9bmV3c2xldHRlciZ1dG1fdGVybT0xOTEyMTImdXRtX2NhbXBhaWduPXByb2dub3Npcw/5daec32c52ba1e0621725115Bbbe1bccf" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on GEDmatch" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none"><meta content="Q2D7KIDWRGG1" itemprop="suid"><meta content="StoryLink" itemprop="type">buying</a> GEDmatch, the genealogy website that helped crack the cold case of the Golden State Killer. The pact is likely to open a new front in the genetics privacy wars. </p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Surprise strains.</strong> Out-of-network doctors at one New York hospital system have <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMTIvb3V0LW9mLW5ldHdvcmstZG9jdG9ycy1pbmZsYXRlLXVuaW9uLXMtY29zdHMtYnktbWlsbGlvbnMtYS15ZWFyP2NtcGlkPUJCRDEyMTIxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTIxMiZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115B3058352c" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on surprise medical bills" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none"><meta content="Q2EHG26KLVR4" itemprop="suid"><meta content="StoryLink" itemprop="type">inflated</a> a union health plan's cost by millions every year. The fight is a demonstration of what's at stake in the struggle over surprise bills.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Inspection ire.</strong> Scrutiny of foreign drug manufacturers by the FDA has fallen in recent years despite <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMTAvZm9yZWlnbi1kcnVnLWluc3BlY3Rpb25zLWJ5LWZkYS1mYWxsLWFtaWQtcmlzaW5nLXF1YWxpdHktZmVhcnM_Y21waWQ9QkJEMTIxMjE5X1BST0cmdXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX3Rlcm09MTkxMjEyJnV0bV9jYW1wYWlnbj1wcm9nbm9zaXM/5daec32c52ba1e0621725115B34670456" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on FDA inspections" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none">increasing worry</a> about the safety and quality of generic medications. The GAO findings echo a Bloomberg investigation.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Listen up.</strong> Want to hear more from Prognosis? Then listen to our podcast, which has explored superbugs, what we share when we share our medical data online, and more. Download it <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly9pdHVuZXMuYXBwbGUuY29tL3VzL3BvZGNhc3QvcHJvZ25vc2lzL2lkMTQ0MDA1MTA4Nj9tdD0yP3NybmQ9cHJvZ25vc2lzLXBvZGNhc3Q/5daec32c52ba1e0621725115B16da72f4" itemprop="StoryLink" itemscope="itemscope" target="_blank" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none">here</a> on Apple devices, and here on <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly9wbGF5Lmdvb2dsZS5jb20vbXVzaWMvbGlzdGVuP3U9MCMvcHMvSWZidXdwNGZyamxtczR3eXducW51Ymh5cmNh/5daec32c52ba1e0621725115Ba33db315" itemprop="StoryLink" itemscope="itemscope" title="Android download link" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none">Android</a>.</p>
<!--[if mso]>
<table width="550"><tr><td><img alt="" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iCN..I4Ldqog/v0/-1x-1.jpg" width="550" /></td></tr></table>
<div style="display:none">
<![endif]-->
<img alt="" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iCN..I4Ldqog/v0/-1x-1.jpg" style="display: block; margin: auto; width: 100%">
<!--[if mso]>
</div>
<![endif]-->
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">
<em>Got this newsletter forwarded to you? Sign up to get it every Thursday by <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vam9pbi80d20vcHJvZ25vc2lzLXNpZ251cD9zb3VyY2U9YXJ0aWNsZQ/5daec32c52ba1e0621725115C4c0c3d89" itemprop="StoryLink" itemscope="itemscope" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none">clicking here</a>. <br><br>We want to hear from you. If you have feedback, questions or potential story ideas, reach out to me at <a href="mailto:tannett@bloomberg.net" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="mailto:tannett@bloomberg.net" style="color: black; border-bottom: 1px solid black; background-color: bisque; text-decoration: none">tannett@bloomberg.net</a></em>
</p>
</td>
</tr>
</table>
<table>
<tbody>
<tr>
<td height="20"> </td>
</tr>
<tr>
<td class="bbiz-wysiwyg-content tout-label"></td>
</tr>
<tr>
<td class="bbiz-wysiwyg-content tout-text"><p><strong>Like Bloomberg’s Prognosis?</strong> <em>Subscribe to Bloomberg.com. You’ll get our unmatched global news coverage and two premium daily newsletters, The Bloomberg Open and The Bloomberg Close, and much, much more. See our <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9zdWJzY3JpcHRpb25zP3V0bV9zb3VyY2U9bmV3c2xldHRlciZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1ldmVuaW5nYnJpZWYmdXRtX3Rlcm09WVlNTURE/58091eb2b84a994a148b4b20Be63e5877">limited-time introductory offer</a>.</em></p>
<p><strong>Download the Bloomberg app:</strong> <em>It’s available <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vY2xpY2svMTAyNzYwMTcuMTgzNTczL2FIUjBjSE02THk5cGRIVnVaWE11WVhCd2JHVXVZMjl0TDJGd2NDOWhjSEJzWlMxemRHOXlaUzlwWkRJNE1UazBNVEE1Tno5d2REMDRPVFE1Sm1OMFBYSmxiR0YxYm1Ob1gyVnRZV2xzSm0xMFBUZy81NmZiZWNjMWU5YThhMjQxMDc4YjQ4YjFCOWU2MDcyNDE/58091eb2b84a994a148b4b20B42849805">for iOS</a> and <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vY2xpY2svMTAyNzYwMTcuMTgzNTczL2FIUjBjSE02THk5d2JHRjVMbWR2YjJkc1pTNWpiMjB2YzNSdmNtVXZZWEJ3Y3k5a1pYUmhhV3h6UDJsa1BXTnZiUzVpYkc5dmJXSmxjbWN1WVc1a2NtOXBaQzV3YkhWekpuSmxabVZ5Y21WeVBYVjBiVjl6YjNWeVkyVWxNMFJsYldGcGJDVXlOblYwYlY5allXMXdZV2xuYmlVelJISmxiR0YxYm1Oby81NmZiZWNjMWU5YThhMjQxMDc4YjQ4YjFCNDMwMDQ2ODA/58091eb2b84a994a148b4b20Bc061af45">Android</a>.</em></p>
<p><em>Before it's here, it's on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can't find anywhere else. <a href="https://link.mail.bloombergbusiness.com/click/15638356.78421/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9wcm9mZXNzaW9uYWwvc29sdXRpb24vYmxvb21iZXJnLXRlcm1pbmFsLw/55088ec43b35d034698d38aeBe3d4e6ab">Learn more</a>.</em></p></td>
</tr>
<tr>
<td height="20"> </td>
</tr>
</tbody>
</table>
<table id="footer" width="100%" align="center" border="0" cellpadding="0" cellspacing="0">
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666; padding-bottom: 10px">You received this message because you are subscribed to Bloomberg's Prognosis newsletter.</td>
</tr>
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666"><a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cHM6Ly9sb2dpbi5ibG9vbWJlcmcuY29tL25ld3NsZXR0ZXJzP3NvdXJjZT1uZXdzbGV0dGVyX3Vuc3ViJmVtYWlsPXB1Ymxpc2gtYmxvb21iZXJnJTQwZW1tYXJlcy5uZXQmaGFzaD1kMTYxYmU4YmU0ZTUyNzFlMGMwZTMzMThiYWVhNjg1Yg/5daec32c52ba1e0621725115B72454815" style="color: #666666; text-decoration: none" alias="  | <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cDovL2Jsb29tYmVyZy5jb20/5daec32c52ba1e0621725115B063c8b1b" style="color: #666666; text-decoration: none" target="_blank">Bloomberg.com</a> | <a href="https://link.mail.bloombergbusiness.com/click/18878954.10847/aHR0cDovL3d3dy5ibG9vbWJlcmcuY29tL2ZlZWRiYWNrP2FsY21waWQ9bW9zdHBvcA/5daec32c52ba1e0621725115B909746aa" style="color: #666666; text-decoration: none" target="_blank">Contact Us</a></td>
</tr>
<tr>
<td height="20" align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666">Bloomberg L.P. 731 Lexington, New York, NY, 10022</td>
</tr>
</table>
<!--[if mso]>
</td></tr>
</table>
</center>
<![endif]-->
</td>
</tr>
</table><custom name="opencounter" type="tracking"><a href=""><img src="https://link.mail.bloombergbusiness.com/img/5daec32c52ba1e0621725115b8n3e.8db/d93ca452.gif" alt="" border="0"></a></custom>